ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

New Carfilzomib Combination Produces Near Remissions

June 29, 2012

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

Funding Opportunities

December 13, 2002

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Diet and Cancer Risk Explored In Studies Presented At AACR Annual Meeting

April 30, 2004

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009